Writes About:
Filter Results:
- Full text PDF available (32)
Publication Year
1985
2018
- This year (1)
- Last 5 years (37)
- Last 10 years (78)
Publication Type
Co-author
Journals and Conferences
Learn More
- Deborah Ann Kuban, Susan L. Tucker, +5 authors Alan Pollack
- International journal of radiation oncology…
- 2008
PURPOSE
To report the long-term results of a randomized radiotherapy dose escalation trial for prostate cancer.
METHODS AND MATERIALS
From 1993 to 1998, a total of 301 patients with stage T1b to T3… (More)
- Jeff Michael Michalski, Hiram Gay, Andrew Jackson, Susan L. Tucker, Joseph O. Deasy
- International journal of radiation oncology…
- 2010
The available dose/volume/outcome data for rectal injury were reviewed. The volume of rectum receiving >or=60 Gy is consistently associated with the risk of Grade >or=2 rectal toxicity or rectal… (More)
- Jerry Barker, Adam Seth Garden, +9 authors Lei-xi Dong
- International journal of radiation oncology…
- 2004
PURPOSE
Many patients receiving fractionated radiotherapy (RT) for head-and-neck cancer have marked anatomic changes during their course of treatment, including shrinking of the primary tumor or… (More)
- Shu-lian Wang, Zhongxing Liao, +6 authors Ritsuko Komaki
- International journal of radiation oncology…
- 2006
PURPOSE
To investigate factors associated with treatment-related pneumonitis in non-small-cell lung cancer patients treated with concurrent chemoradiotherapy.
PATIENTS AND METHODS
We… (More)
- William S. Velasquez, Fernando F Cabanillas, +7 authors Forrest Swan
- Blood
- 1988
Ninety patients with progressive recurrent lymphoma were treated with a combination of cisplatin 100 mg/m2 intravenously (IV) by continuous infusion over 24 hours, followed by cytosine arabinoside in… (More)
- Gary L Clayman, J Jack Lee, +9 authors Scott Michael Lippman
- Journal of clinical oncology : official journal…
- 2005
PURPOSE
To identify nonmelanoma skin cancer patients with squamous cell carcinoma (SCC) who are at greatest risk of disease-specific mortality.
PATIENTS AND METHODS
Prospectively enrolled patients… (More)
- Anupama Munshi, John F. Kurland, +6 authors Raymond E. Meyn
- Clinical cancer research : an official journal of…
- 2005
PURPOSE
Histone deacetylase (HDAC) inhibitors have emerged recently as promising anticancer agents. They arrest cells in the cell cycle and induce differentiation and cell death. The antitumor… (More)
- Chiaojung Jillian Tsai, Theresa M. Hofstede, +5 authors Lei-xi Dong
- International journal of radiation oncology…
- 2013
PURPOSE
To determine the association between radiation doses delivered to the mandible and the occurrence of osteoradionecrosis (ORN).
METHODS AND MATERIALS
We reviewed the records of 402… (More)
- Sue S Yom, Zhongxing Liao, +8 authors Ritsuko Komaki
- International journal of radiation oncology…
- 2007
PURPOSE
To investigate the rate of high-grade treatment-related pneumonitis (TRP) in patients with advanced non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and… (More)
- Khandan Keyomarsi, Susan L. Tucker, +9 authors Sarah S. Bacus
- The New England journal of medicine
- 2002
BACKGROUND
Cyclin E, a regulator of the cell cycle, affects the behavior of breast-cancer cells. We investigated whether levels of cyclin E in the tumor correlated with survival among patients with… (More)